Mercury in vaccines;Le mercure et les vaccins

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 8, 2003, Pages 1501-1510

  Hessel, Luc ^a   Giroud, Jean Paul ^b   Gueniot, Maurice ^b  

^a SANOFI PASTEUR   (France)

^b NONE

Author keywords

Behavioral symptoms; Hypersensitivity; Mercury; Thimerosal; Vaccines

Indexed keywords

HEPATITIS B ANTIGEN; MERCURY; MERCURY DERIVATIVE; METHYLMERCURY; PRESERVATIVE; THIOMERSAL; VACCINE;

ALLERGY; AUTISM; BACTERIUM CONTAMINATION; BLOOD LEVEL; DELAYED HYPERSENSITIVITY; DEVELOPING COUNTRY; DEVELOPMENTAL DISORDER; DRUG FORMULATION; DRUG SCREENING; EXPOSURE; FECES LEVEL; FOOD; FOOD AND DRUG ADMINISTRATION; FRANCE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEPATITIS B; HUMAN; HYPERSENSITIVITY REACTION; HYPOTHESIS; IMMUNIZATION; MOTHER; NEUROLOGIC DISEASE; NEUROTOXICITY; RELIABILITY; REVIEW; SKIN TEST; TREATMENT CONTRAINDICATION; UNITED STATES; URINE LEVEL; VACCINATION; WORLD HEALTH ORGANIZATION; CHEMISTRY; DRUG HYPERSENSITIVITY; EUROPE; PRESCHOOL CHILD;

AUTISTIC DISORDER; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; EUROPE; GOVERNMENT AGENCIES; HUMANS; MERCURY; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; UNITED STATES; VACCINES;

EID: 3142707369     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33886-5     Document Type: Review

References (18)

1. CLARKSON T.W., MAGOS L., MUERS G.J. - The Toxicology of Mercury - Current Exposures and Clinical Manifestations. N.E.J.M., 2003, 249, 1731-1737.
2. PICHICHERO M.E., CERNICHIARI E., LOPRICATO J., TREANOR J. - Mercury concentration and metabolism in infants receiving vaccines containing thiomersal : a descriptive study. Lancet, 2002, 360, 1737-1741.
3. STRATTON K., GABIE A., MCCORMICK M.C. - eds. Immunization Safety Review : Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC, National Academy Press, 2001.
4. HVIID A., STELLFELD M., WOHLFAHRT J., MEDBYE M. - Association between thimerosal-containing vaccine and autism. JAMA, 2003, 290, 1763-1766.
5. MADSEN K.M., LAURITSEN M.B., PEDERSEN C.B. et al. - Thimerosal and the occurrence of autism : negative ecological evidence from Danish population-based data. Pediatrics, 2003, 112, 604-606.
6. STEHR-GREEN P. et al. - Autism and thimerosal-containing vaccines - lack of consistent evidence for an association. Am. J. Prev. Med., 2003, 25, 101-106.
7. NELSON K.B., BAUMANN M.L. - Thimerosal and Autism ? Pediatrics, 2003, 111, 674-679.
8. Organisation Mondiale de la Santé. Le thimérosal comme agent de conservation des vaccins. Relevé épidémiologique hebdomadaire, 2000, 75, 12-16.
9. Organisation Mondiale de la Santé. Global Advisory Committee on Vaccine Safety. Relevé Épidémiologique Hebdomadaire, 2002, 77, 389-394.
10. Cox N.H., FORSYTH A. - Thimerosal allergy and vaccination reactions. Contact Dermatitis, 1988, 18, 229-233.
11. EMEA Public statement on thiomersal-containing medicinal products, July 8, 1999.
12. EMEA Position Statement : recent developments concerning thiomersal in vaccines, 29 June 2000.
13. AFSSAPS, thiomersal utilisé comme conservateur dans certains médicaments, 8 juillet 1999.
14. AFSSAPS Communiqué de Presse Thiomersal, 4 juillet 2000.
15. Organisation Mondiale de la Santé. Mercury environment health criteria. Doc 1, Geneva, Switzerland, 1976.
16. Organisation Mondiale de la Santé. Le thimérosal comme agent de conservation des vaccins. Relevé Epidémiologique Hebdomadaire, 2000, 75, 12-16.
17. Organisation Mondiale de la Santé. Vaccine and Biologicals Committee : recommendations from the Strategic Advisory Group of Experts. WER 2002, 77, 305-312.
18. Organisation Mondiale de la Santé. The impact of thiomersal on quality safety and efficacy of vaccines : regulatory perspective WHO consultation, 15-16 April 2002.